Pediatric Nephrology

, Volume 2, Issue 1, pp 22–26 | Cite as

Long term follow-up of bone mineral status in children with renal disease

  • Russell W. Chesney
  • Philip Rose
  • Richard B. Mazess
  • Hector F. DeLuca
Original Article


Bone mineral content (BMC) was measured by photon absorptiometry in the non-dominant forearm of children with chronic renal failure followed for a total of 2472 months. From 48 children, 302 measurements were made, and changes which occurred in BMC over time were correlated with several factors. Patients were divided into those who had received glucocorticoids (group 1) and those who had not (group 2). Group 1 patients had a lower mean serum creatinine (Cr) (p<0.05), a lower growth velocity (p>0.02) and were more demineralized than group 2 patients. There was no correlation between BMC and height velocity or estimated creatinine clearance. BMC and height Z-score (SDS) were highly correlated. Over the period of study, group 1 patients remained shorter, had a lower height velocity, a lower BMC Z-score and a lower BMC for each serum creatinine level. Long-term therapeutic intervention with oral 1,25(OH)2D improved bone mineral status in three children in the nonsteroid group, but none of those in the steroid group. This study demonstrates that steroid administration is probably the most important factor causing bone demineralization, possibly even more important than renal failure.

Key words

Bone mineral content Stature Chronic renal failure Glucocorticoids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mazess RB, Cameron JR (1972) Growth of bone in school children: comparison of radiographic morphometry and photon absorptiometry. Growth 36: 77–92Google Scholar
  2. 2.
    Mazess RB, Cameron JR (1974) Bone mineral content in normal U.S. whites. In: Mazess RB (ed) International Conference on Bone Mineral Measurement. US Department of Health, Education and Welfare, pp 228–238Google Scholar
  3. 3.
    Landin L, Nilsson BOE (1981) Forearm bone mineral content in children normative data. Acta Paediatr Scand 70: 919–923Google Scholar
  4. 4.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL (1983) Long-term influence of calcitriol (1,25(OH)2D) and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71: 559–567Google Scholar
  5. 5.
    Rosenbloom AL, Lezotte DC, Weber FT, Gudat J, Heller DR, Weber ML, Klein S, Kennedy BB (1977) Diminution of bone mass in childhood diabetes. Diabetica 26: 1052–1055Google Scholar
  6. 6.
    Mischler EH, Chesney J, Chesney RW, Mazess RB (1979) Demineralization in cystic fibrosis. Am J Dis Child 133: 632–635Google Scholar
  7. 7.
    Shore RM, Chesney RW, Mazess RB, Rose PG, Bargmann GJ (1982) Skeletal demineralization in Turner's syndrome. Calcif Tissue Int 34: 519–522Google Scholar
  8. 8.
    Chesney RW, Shore RM (1982) The noninvasive determination of bone mineral content by photon absorptiometry. Am J Dis Child 136: 578–580Google Scholar
  9. 9.
    Barden HS, Mazess RB, Chesney RW, Rose P, Chun RM (1982) Bone status of children receiving anticonvulsant therapy. Metab Bone Dis Relat Res 4: 37–43Google Scholar
  10. 10.
    Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1980) Bone mineral status in growth hormone deficiency. J Pediatr 96: 393–396Google Scholar
  11. 11.
    Hanly JG, McKenna MJ, Quigley C, Freaney R, Muldowney FP, Fitzgerald MX (1985) Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 56: 377–385Google Scholar
  12. 12.
    DeLuca HF, Schnoes HK (1983) Vitamin D recent advances. Annu Rev Biochem 52: 411–439Google Scholar
  13. 13.
    Chesney RW, Mazess RB, Rose PG, Jax DK (1977) Bone mineral status measured by direct photon absorptiometry in childhood renal disease. Pediatrics 60: 864–872Google Scholar
  14. 14.
    Chesney RW, Mazess RB, DeLuca HF (1980) The long-term influence of calcitriol on growth patterns in childhood renal osteodystrophy. In: Symposium: a clinical review of calcitriol. Excerpta Medica, Amsterdam-Princeton, p 7Google Scholar
  15. 15.
    Chesney RW, Mazess RB, Rose PG, Jax DK (1978) Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 132: 768–772Google Scholar
  16. 16.
    Chesney RW, Rose PG, Mazess RB (1984) Persistence of diminished bone mineral content following renal transplantation in childhood. Pediatrics 73: 459–466Google Scholar
  17. 17.
    Schwartz GJ, Haycock GB, Edelman CM Jr, et al. (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263Google Scholar
  18. 18.
    Barratt TM, Broyer M, Chantler C, Gilli G, Guest G, Marti-Henneberg C, Preece MA, Rigden SPA (1986) Assessment of growth. Am J Kidney Dis 6: 340–346Google Scholar
  19. 19.
    Chesney RW, Holliday MA (1986) Growth in children (with Renal Introduction and Purpose Statement): Third International Workshop on Chronic Renal Insufficiency in children. Am J Kidney Dis 7: 225Google Scholar
  20. 20.
    Alfrey AC (1983) Aluminum. Adv Clin Chem 23: 69–91Google Scholar
  21. 21.
    Andreoli S, Bergstein JM, Sherrard DJ (1984) Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310: 1079–1984Google Scholar
  22. 22.
    Sedman AB, Miller NL, Warady BA, et. al. (1984) Aluminum loading in children with chronic renal failure. Kidney Int 26: 201–204Google Scholar
  23. 23.
    Griswold WR, Reznik V, Mendoza SA, et al. (1983) Accumulation of aluminum hydroxide. Pediatrics 71: 56–58Google Scholar
  24. 24.
    Bettinelli A, Bianchi ML, Aimini E, Ortolani S, Soldati L, Edefonti A (1986) Effects of 1,25-dihydroxyvitamin-D3 treatment on mineral balance in children with end stage renal disease undergoing chronic hemofiltration. Pediatr Res 20: 5–8Google Scholar

Copyright information

© IPNA 1988

Authors and Affiliations

  • Russell W. Chesney
    • 1
  • Philip Rose
    • 2
  • Richard B. Mazess
    • 3
  • Hector F. DeLuca
    • 4
  1. 1.Department of PediatricsUniversity of California, Davis Medical CenterSacramentoUSA
  2. 2.Department of PediatricsUniversity of WisconsinMadisonUSA
  3. 3.Department of Medical PhysicsUniversity of WisconsinMadisonUSA
  4. 4.Department of BiochemistryUniversity of WisconsinMadisonUSA

Personalised recommendations